Atlas Trials

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

Clinical trial NCT03460405 · COMPLETED

Trial details

NCT number
NCT03460405
Sponsor
PT Bio Farma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Safety IssuesImmunogenicity
Start date
2018-07-16
Primary completion
2019-12-31
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.